Structure

InChI Key USSIQXCVUWKGNF-UHFFFAOYSA-N
Smiles CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c1ccccc1
InChI
InChI=1S/C21H27NO/c1-5-20(23)21(16-17(2)22(3)4,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15,17H,5,16H2,1-4H3

Physicochemical Descriptors

Property Name Value
Molecular Formula C21H27NO
Molecular Weight 309.45
AlogP 4.29
Hydrogen Bond Acceptor 2.0
Hydrogen Bond Donor 0.0
Number of Rotational Bond 7.0
Polar Surface Area 20.31
Molecular species BASE
Aromatic Rings 2.0
Heavy Atoms 23.0
Assay Description Organism Bioactivity Reference
Binding affinity against opioid receptor kappa 1 using [3H]- U-69,593 radioligand None 512.0 nM
Binding affinity against mu-opiate receptor (human) using [3H]DAMGO radioligand None 4.1 nM
Inhibition of rat aldehyde oxidase Rattus norvegicus 30.0 nM
Inactivation of C-terminal His4-tagged human CYP2B6 lacking 21 N-terminal residues assessed as decrease in enzyme catalytic activity at 100 uM for 15 mins by spectral analysis in presence of NADPH Homo sapiens 58.0 %
Inactivation of C-terminal His4-tagged human CYP2B6 lacking 21 N-terminal residues assessed as native heme loss at 50 uM at 37 degC for 20 mins by HPLC analysis in presence of NADPH Homo sapiens 75.0 %
Inactivation of C-terminal His4-tagged human CYP2B6 lacking 21 N-terminal residues assessed as decrease in CO difference spectrum at 100 uM for 15 mins by spectral analysis in presence of NADPH Homo sapiens 61.0 %
Displacement of [3H]DAMGO from human mu opioid receptor expressed in HEK293 cell membrane incubated for 60 mins by radioligand binding assay Homo sapiens 13.0 nM

Related Entries

Environmental Exposure

Countries
Croatia
Czech Republic
Germany
Hungary
Romania
Serbia
Slovakia
Slovenia
USA

Cross References

Resources Reference
ChEBI 167309
ChEMBL CHEMBL651
DrugBank DB00333
DrugCentral 1728
FDA SRS UC6VBE7V1Z
Human Metabolome Database HMDB0014477
Guide to Pharmacology 5458
KEGG C07163
PharmGKB PA450401
PubChem 4095
SureChEMBL SCHEMBL34140